Cleo Life Sciences is Pharmaceuticals in United States that focus on right technical expertise business. Founded in 2004. They cover business area such as provider, pharmaceutical consulting service, a hybrid model, Chemistry and contract manufacturing organization, pharmaceutical formulation development, pharmaceutical manufacturer, product, accelerated timeline, management.
2004
( 20 years old in 2024 )
Right Technical Expertise
-
329 Oyster Point Boulevard
Floor 3, South San Francisco
San Francisco, CA 94080
United States
Private
providerpharmaceutical consulting servicea hybrid modelChemistry and contract manufacturing organizationpharmaceutical formulation developmentpharmaceutical manufacturerproductaccelerated timelinemanagement
* We use standard office opening hours in near Cleo Life Sciences's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Cleo Life Sciences is Pharmaceuticals business from United States that founded in 2004 (20 years old in 2024), Cleo Life Sciences business is focusing on Right Technical Expertise.
Cleo Life Sciences headquarter office and corporate office address is located in 329 Oyster Point Boulevard Floor 3, South San Francisco San Francisco, CA 94080 United States.
Cleo Life Sciences was founded in United States.
In 2024, Cleo Life Sciences is currently focus on right technical expertise sector.
Above is snippet of Google Trends for "right technical expertise" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Cleo Life Sciences, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.